2-166272407-T-C

Variant summary

Our verdict is Benign. The variant received -7 ACMG points: 0P and 7B. BP4_ModerateBP6BS2

The NM_001365536.1(SCN9A):​c.3343A>G​(p.Ser1115Gly) variant causes a missense change. The variant allele was found at a frequency of 0.000489 in 1,576,122 control chromosomes in the GnomAD database, including 2 homozygotes. In-silico tool predicts a benign outcome for this variant. Variant has been reported in ClinVar as Conflicting classifications of pathogenicity (no stars). Another variant affecting the same amino acid position, but resulting in a different missense (i.e. S1115R) has been classified as Likely benign.

Frequency

Genomes: 𝑓 0.00024 ( 0 hom., cov: 31)
Exomes 𝑓: 0.00052 ( 2 hom. )

Consequence

SCN9A
NM_001365536.1 missense

Scores

1
11
7

Clinical Significance

Conflicting classifications of pathogenicity criteria provided, conflicting classifications U:4B:4

Conservation

PhyloP100: 4.79

Publications

5 publications found
Variant links:
Genes affected
SCN9A (HGNC:10597): (sodium voltage-gated channel alpha subunit 9) This gene encodes a voltage-gated sodium channel which plays a significant role in nociception signaling. Mutations in this gene have been associated with primary erythermalgia, channelopathy-associated insensitivity to pain, and paroxysmal extreme pain disorder. [provided by RefSeq, Aug 2009]
SCN1A-AS1 (HGNC:54069): (SCN1A and SCN9A antisense RNA 1)

Genome browser will be placed here

ACMG classification

Classification was made for transcript

Our verdict: Benign. The variant received -7 ACMG points.

BP4
Computational evidence support a benign effect (MetaRNN=0.14048877).
BP6
Variant 2-166272407-T-C is Benign according to our data. Variant chr2-166272407-T-C is described in ClinVar as [Conflicting_classifications_of_pathogenicity]. Clinvar id is 331972.We mark this variant Likely_benign, oryginal submission is: [Conflicting_classifications_of_pathogenicity].
BS2
High Homozygotes in GnomAdExome4 at 2 AD,SD,AR gene

Transcripts

RefSeq

Gene Transcript HGVSc HGVSp Effect Exon rank MANE Protein UniProt
SCN9ANM_001365536.1 linkc.3343A>G p.Ser1115Gly missense_variant Exon 17 of 27 ENST00000642356.2 NP_001352465.1

Ensembl

Gene Transcript HGVSc HGVSp Effect Exon rank TSL MANE Protein Appris UniProt
SCN9AENST00000642356.2 linkc.3343A>G p.Ser1115Gly missense_variant Exon 17 of 27 NM_001365536.1 ENSP00000495601.1 Q15858-1
SCN9AENST00000303354.11 linkc.3343A>G p.Ser1115Gly missense_variant Exon 17 of 27 5 ENSP00000304748.7 Q15858-1
SCN9AENST00000409672.5 linkc.3310A>G p.Ser1104Gly missense_variant Exon 17 of 27 5 ENSP00000386306.1 Q15858-3
SCN9AENST00000645907.1 linkc.3310A>G p.Ser1104Gly missense_variant Exon 17 of 27 ENSP00000495983.1 Q15858-4

Frequencies

GnomAD3 genomes
AF:
0.000237
AC:
36
AN:
152118
Hom.:
0
Cov.:
31
show subpopulations
Gnomad AFR
AF:
0.0000965
Gnomad AMI
AF:
0.00
Gnomad AMR
AF:
0.00
Gnomad ASJ
AF:
0.00
Gnomad EAS
AF:
0.000194
Gnomad SAS
AF:
0.00
Gnomad FIN
AF:
0.000471
Gnomad MID
AF:
0.00
Gnomad NFE
AF:
0.000382
Gnomad OTH
AF:
0.00
GnomAD2 exomes
AF:
0.000359
AC:
80
AN:
223124
AF XY:
0.000300
show subpopulations
Gnomad AFR exome
AF:
0.0000717
Gnomad AMR exome
AF:
0.0000319
Gnomad ASJ exome
AF:
0.00
Gnomad EAS exome
AF:
0.00
Gnomad FIN exome
AF:
0.000397
Gnomad NFE exome
AF:
0.000657
Gnomad OTH exome
AF:
0.000365
GnomAD4 exome
AF:
0.000515
AC:
734
AN:
1423886
Hom.:
2
Cov.:
29
AF XY:
0.000477
AC XY:
336
AN XY:
704498
show subpopulations
African (AFR)
AF:
0.000123
AC:
4
AN:
32634
American (AMR)
AF:
0.00
AC:
0
AN:
41586
Ashkenazi Jewish (ASJ)
AF:
0.00
AC:
0
AN:
24660
East Asian (EAS)
AF:
0.00
AC:
0
AN:
38990
South Asian (SAS)
AF:
0.000110
AC:
9
AN:
81632
European-Finnish (FIN)
AF:
0.000325
AC:
17
AN:
52268
Middle Eastern (MID)
AF:
0.000354
AC:
2
AN:
5642
European-Non Finnish (NFE)
AF:
0.000625
AC:
680
AN:
1087622
Other (OTH)
AF:
0.000374
AC:
22
AN:
58852
Allele Balance Distribution
Red line indicates average allele balance
Average allele balance: 0.478
Heterozygous variant carriers
0
33
66
99
132
165
0.00
0.20
0.40
0.60
0.80
0.95
Allele balance

Age Distribution

Exome Het
Exome Hom
Variant carriers
0
26
52
78
104
130
<30
30-35
35-40
40-45
45-50
50-55
55-60
60-65
65-70
70-75
75-80
>80
Age
GnomAD4 genome
AF:
0.000236
AC:
36
AN:
152236
Hom.:
0
Cov.:
31
AF XY:
0.000269
AC XY:
20
AN XY:
74428
show subpopulations
African (AFR)
AF:
0.0000962
AC:
4
AN:
41560
American (AMR)
AF:
0.00
AC:
0
AN:
15270
Ashkenazi Jewish (ASJ)
AF:
0.00
AC:
0
AN:
3472
East Asian (EAS)
AF:
0.000195
AC:
1
AN:
5140
South Asian (SAS)
AF:
0.00
AC:
0
AN:
4832
European-Finnish (FIN)
AF:
0.000471
AC:
5
AN:
10620
Middle Eastern (MID)
AF:
0.00
AC:
0
AN:
294
European-Non Finnish (NFE)
AF:
0.000382
AC:
26
AN:
68020
Other (OTH)
AF:
0.00
AC:
0
AN:
2116
Allele Balance Distribution
Red line indicates average allele balance
Average allele balance: 0.494
Heterozygous variant carriers
0
2
4
6
8
10
0.00
0.20
0.40
0.60
0.80
0.95
Allele balance

Age Distribution

Genome Het
Variant carriers
0
2
4
6
8
10
<30
30-35
35-40
40-45
45-50
50-55
55-60
60-65
65-70
70-75
75-80
>80
Age
Alfa
AF:
0.000298
Hom.:
0
Bravo
AF:
0.000144
TwinsUK
AF:
0.000539
AC:
2
ALSPAC
AF:
0.00
AC:
0
ESP6500AA
AF:
0.00
AC:
0
ESP6500EA
AF:
0.000611
AC:
5
ExAC
AF:
0.000464
AC:
56

ClinVar

Significance: Conflicting classifications of pathogenicity
Submissions summary: Uncertain:4Benign:4
Revision: criteria provided, conflicting classifications
LINK: link

Submissions by phenotype

not provided Uncertain:2
Mar 22, 2022
ARUP Laboratories, Molecular Genetics and Genomics, ARUP Laboratories
Significance:Uncertain significance
Review Status:criteria provided, single submitter
Collection Method:clinical testing

The SCN9A c.3310A>G; p.Ser1104Gly variant (rs201984007) is reported in the literature in an individual affected with small fiber neuropathy that also carried a second missense variant in SCN9A (Kelley 2020). The p.Ser1104Gly variant is found in the non-Finnish European population with an allele frequency of 0.064% (74/115960 alleles) in the Genome Aggregation Database. The serine at codon 1104 is highly conserved, but computational analyses are uncertain whether this variant is neutral or deleterious (REVEL: 0.552). Due to limited information, the clinical significance of the p.Ser1104Gly variant is uncertain at this time. References: Kelley et al., Association of small-fiber polyneuropathy with three previously unassociated rare missense SCN9A variants. Can J Pain. 2020;4(1):19-29. PMID 32719824. -

May 21, 2025
GeneDx
Significance:Uncertain significance
Review Status:criteria provided, single submitter
Collection Method:clinical testing

Identified by whole exome sequencing in an individual with small fiberpredominant sensory neuropathy who was also found to have a second SCN9A missense variant (PMID: 32719824); In silico analysis supports that this missense variant has a deleterious effect on protein structure/function; This variant is associated with the following publications: (PMID: 26264438, 32719824) -

Inborn genetic diseases Uncertain:1
Jul 03, 2023
Ambry Genetics
Significance:Uncertain significance
Review Status:criteria provided, single submitter
Collection Method:clinical testing

Unlikely to be causative of SCN9A-related neuropathic pain syndromes (AD) Based on insufficient or conflicting evidence, the clinical significance of this alteration remains unclear. -

Channelopathy-associated congenital insensitivity to pain, autosomal recessive Uncertain:1
Jan 13, 2018
Illumina Laboratory Services, Illumina
Significance:Uncertain significance
Review Status:criteria provided, single submitter
Collection Method:clinical testing

This variant was observed in the ICSL laboratory as part of a predisposition screen in an ostensibly healthy population. It had not been previously curated by ICSL or reported in the Human Gene Mutation Database (HGMD: prior to June 1st, 2018), and was therefore a candidate for classification through an automated scoring system. Utilizing variant allele frequency, disease prevalence and penetrance estimates, and inheritance mode, an automated score was calculated to assess if this variant is too frequent to cause the disease. Based on the score, this variant could not be ruled out of causing disease and therefore its association with disease required further investigation. A literature search was performed for the gene, cDNA change, and amino acid change (if applicable). No publications were found based on this search. This variant was therefore classified as a variant of unknown significance for this disease. -

Primary erythromelalgia Benign:1
Jan 13, 2018
Illumina Laboratory Services, Illumina
Significance:Benign
Review Status:criteria provided, single submitter
Collection Method:clinical testing

This variant was observed in the ICSL laboratory as part of a predisposition screen in an ostensibly healthy population. It had not been previously curated by ICSL or reported in the Human Gene Mutation Database (HGMD: prior to June 1st, 2018), and was therefore a candidate for classification through an automated scoring system. Utilizing variant allele frequency, disease prevalence and penetrance estimates, and inheritance mode, an automated score was calculated to assess if this variant is too frequent to cause the disease. Based on the score and internal cut-off values, a variant classified as benign is not then subjected to further curation. The score for this variant resulted in a classification of benign for this disease. -

Generalized epilepsy with febrile seizures plus, type 7;C2752089:Neuropathy, hereditary sensory and autonomic, type 2A Benign:1
Jan 06, 2025
Labcorp Genetics (formerly Invitae), Labcorp
Significance:Likely benign
Review Status:criteria provided, single submitter
Collection Method:clinical testing

- -

Small fiber neuropathy Benign:1
Jun 14, 2016
Illumina Laboratory Services, Illumina
Significance:Likely benign
Review Status:criteria provided, single submitter
Collection Method:clinical testing

- -

Paroxysmal extreme pain disorder Benign:1
Jan 13, 2018
Illumina Laboratory Services, Illumina
Significance:Benign
Review Status:criteria provided, single submitter
Collection Method:clinical testing

This variant was observed in the ICSL laboratory as part of a predisposition screen in an ostensibly healthy population. It had not been previously curated by ICSL or reported in the Human Gene Mutation Database (HGMD: prior to June 1st, 2018), and was therefore a candidate for classification through an automated scoring system. Utilizing variant allele frequency, disease prevalence and penetrance estimates, and inheritance mode, an automated score was calculated to assess if this variant is too frequent to cause the disease. Based on the score and internal cut-off values, a variant classified as benign is not then subjected to further curation. The score for this variant resulted in a classification of benign for this disease. -

Computational scores

Source: dbNSFP v4.3

Name
Calibrated prediction
Score
Prediction
AlphaMissense
Benign
0.069
BayesDel_addAF
Benign
-0.13
T
BayesDel_noAF
Uncertain
-0.060
CADD
Benign
23
DANN
Uncertain
0.99
DEOGEN2
Uncertain
0.53
.;D;.;.;D;.
Eigen
Uncertain
0.24
Eigen_PC
Uncertain
0.36
FATHMM_MKL
Pathogenic
0.99
D
LIST_S2
Uncertain
0.90
D;.;D;D;D;D
M_CAP
Benign
0.048
D
MetaRNN
Benign
0.14
T;T;T;T;T;T
MetaSVM
Uncertain
0.17
D
MutationAssessor
Uncertain
2.6
.;M;.;.;M;M
PhyloP100
4.8
PrimateAI
Benign
0.48
T
PROVEAN
Uncertain
-3.2
D;.;.;.;.;D
REVEL
Uncertain
0.55
Sift
Uncertain
0.012
D;.;.;.;.;D
Sift4G
Benign
0.19
T;T;.;.;.;T
Vest4
0.35
MVP
0.76
MPC
0.23
ClinPred
0.052
T
GERP RS
5.4
Varity_R
0.38
gMVP
0.36
Mutation Taster
=15/85
disease causing

Splicing

Name
Calibrated prediction
Score
Prediction
SpliceAI score (max)
0.0
Details are displayed if max score is > 0.2

Find out detailed SpliceAI scores and Pangolin per-transcript scores at spliceailookup.broadinstitute.org

Publications

Other links and lift over

dbSNP: rs201984007; hg19: chr2-167128917; API